Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

BACKGROUND: Radium-223 improves overall survival (OS) in men with bone metastatic castration-resistant prostate cancer (mCRPC). While the exact mechanism behind this survival benefit remains unclear, radium-induced immunological mechanisms might contribute to the OS advantage. We performed a compreh...

Descripción completa

Detalles Bibliográficos
Autores principales: Creemers, Jeroen H. A., van der Doelen, Maarten J., van Wilpe, Sandra, Hermsen, Rick, Duiveman-de Boer, Tjitske, Somford, Diederik M., Janssen, Marcel J. R., Sedelaar, J. P. Michiel, Mehra, Niven, Textor, Johannes, Westdorp, Harm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167220/
https://www.ncbi.nlm.nih.gov/pubmed/34084750
http://dx.doi.org/10.3389/fonc.2021.667658

Ejemplares similares

Ejemplares similares